An H1N1 flu patient who has completely recovered was identified at the Health Ministry's central virus lab as having a strain resistant to treatment by Tamiflu, the antiviral drug that is being prescribed to high-risk H1N1 patients.
The same has happened in other countries around the world.
The ministry said Thursday that it was continuing to study the resistant strain and its significance, but was not changing its policy on dealing with the H1N1 flu.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>